Isotretinoin Basics (Isotretinoin)

Isotretinoin binds to retinoic acid receptors in skin cells, leading to reduced size and activity of sebaceous glands, lower sebum production, normalization of follicular keratinization, and anti‑inflammatory effects. These actions diminish the environment that supports acne‑causing bacteria and reduce lesion formation.

The exact dose of isotretinoin is set by the prescribing clinician based on the patient’s body weight, severity of acne, baseline laboratory values, and tolerance to therapy. Dosage adjustments may be made during treatment according to clinical response and safety monitoring.

Isotretinoin is classified as pregnancy category X because it is highly teratogenic. It must not be used by pregnant women, and effective contraception is required for women of child‑bearing potential. Use during breastfeeding is also contraindicated due to potential harm to the infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and import documentation.

Compared with oral antibiotics or hormonal agents, isotretinoin provides a disease‑modifying effect by targeting sebum production and follicular keratinization, often achieving longer‑lasting remission after a finite course. However, its safety profile requires careful monitoring, whereas many alternatives have a more favorable side‑effect spectrum.

Store the product at ambient temperature below 25 °C in its original packaging. Protect it from moisture, excessive heat and direct light to maintain potency throughout its shelf life.

Isotretinoin Basics is taken orally, usually with a meal to improve absorption. The exact dosing schedule, including frequency and duration, is determined by the prescribing physician based on individual patient factors.

The most serious risks include teratogenicity (birth defects), severe depression or suicidal thoughts, significant liver enzyme elevation, hypertriglyceridemia, and inflammatory bowel disease. Patients should be monitored closely for these events and advised to seek immediate medical attention if they occur.

Isotretinoin should not be used by pregnant or nursing women, individuals with known hypersensitivity to retinoids, patients with uncontrolled liver disease or severe hyperlipidaemia, and those taking contraindicated medications such as tetracyclines or high‑dose vitamin A without medical supervision.